Medications

Repurposed drug shows promise for treating cardiac arrhythmias

Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.

Neuroscience

Protein interactions and brain function

Forty years since its discovery, much remains to be discovered about an enzyme called CaMKII that plays a key role in shaping learning and memory in the brain.

Neuroscience

Researchers discover the key to long-term memory

After a 30-year quest, a Brandeis professor has discovered the molecule that stores long-term memories—it's called calcium/calmodulin dependent protein kinase, or CaMKII for short. The results were published on September ...

page 1 from 2